The Taming of the TAMs

Area of Science:

• Oncology
• Immunology
• Neuro-oncology

Background:

• Tumor-associated macrophages and microglia (TAMs) play a critical role in cancer progression, particularly in glioblastoma (GBM).
• Colony-stimulating factor-1 receptor (CSF-1R) inhibitors are being investigated as a therapeutic strategy targeting TAMs in GBM.
• Understanding resistance mechanisms is crucial for developing effective cancer therapies.

Purpose of the Study:

• To elucidate the molecular mechanisms of acquired resistance to CSF-1R inhibitors in glioblastoma.
• To investigate the role of TAMs in mediating treatment resistance.
• To identify potential therapeutic targets for overcoming resistance to CSF-1R inhibitors in GBM.

Main Methods:

• Analysis of molecular pathways involved in TAMs and glioblastoma progression.
• In vivo and in vitro studies to assess the effects of CSF-1R inhibitors.
• Investigation of insulin-like growth factor 1 (IGF-1) expression in TAMs.

Main Results:

• Targeting TAMs with CSF-1R inhibitors demonstrated an initial antitumor response in GBM.
• Acquired resistance to CSF-1R inhibitors was observed in GBM models.
• This resistance was mediated by the induction of insulin-like growth factor 1 (IGF-1) expression in TAMs.

Conclusions:

• CSF-1R inhibitors can induce an antitumor response in glioblastoma by targeting TAMs.
• The development of resistance to CSF-1R inhibitors is linked to IGF-1 upregulation in TAMs.
• Targeting the IGF-1 pathway in TAMs may represent a strategy to overcome resistance and improve GBM treatment outcomes.